Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?

INTRODUCTION: Non-clear cell renal cell carcinoma (nccRCC) and sarcomatoid renal cell carcinoma (sRCC) are underrepresented in clinical trials. Treatment approaches are frequently extrapolated from data of clear cell renal cell carcinoma, in which pazopanib is non-inferior to sunitinib. We aim to co...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Ecancermedicalscience
Κύριοι συγγραφείς: Bonadioa, Renata Colombo, Velho, Pedro Isaacsson, Marta, Guilherme Nader, Nardo, Mirella, Souza, Manoel Carlos LA, Muniz, David QB, Bezerra, Regis OF, Bispo, Raisa KA, Faraj, Sheila F, Bastos, Diogo A, Dzik, Carlos
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Cancer Intelligence 2019
Θέματα:
Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6946421/
https://ncbi.nlm.nih.gov/pubmed/31921344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2019.973
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια